PL BioScience
PrivateLast Round
Series A
Aug 12, 2024
Total Funding Raised
$13.06M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
PL BioScience is a biotechnology company that develops and manufactures animal-free cell culture media, specifically Human Platelet Lysate (HPL), for use in regenerative medicine, cell therapy, and biopharmaceutical research.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
PL BioScience Comparables
Compare PL BioScience with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Mill Creek Life Sciences | 87% | |
| AventaCell BioMedical Corp. | 86% | |
| Compass Biomedical | 84% | |
PL BioScience Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Aug 12, 2024 | ||||
| Seed | May 21, 2021 |
Key People
Founding team and executive leadership
PL BioScience Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BORN2GROW | Seed |
| Better Ventures | Series A |
| better ventures | Series A |
| Born2grow | Seed |
| Tech Vision Fonds | Series A |
| Brightlands Venture Partners | Series A, Seed |
| Federal Ministry for Economic Affairs and Energy | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 20, 2026
Exclusive agreement with Summit Pharmaceuticals International Corporation for the Japanese market.
- Dec 22, 2025
Added Iwai Chem, a chemicals/life sciences distributor, as a customer.
PL BioScience Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about PL BioScience's valuation, stock price, and market status.